Trials / Recruiting
RecruitingNCT06050148
Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections
- Status
- Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Helsinki University Central Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
This study investigates Faecal microbiota transplantation (FMT) in prevention of recurrent urinary tract infections (UTIs) caused either by sensitive E. coli or ESBL-E. coli.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Feacal microbial transplantation (FMT) | Feacal microbial transplantation (FMT) |
| OTHER | Placebo transplantation (PT) | Transplantation with coloured 0,9% NaCl-solution |
Timeline
- Start date
- 2023-08-01
- Primary completion
- 2028-12-31
- Completion
- 2029-12-31
- First posted
- 2023-09-22
- Last updated
- 2023-09-22
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT06050148. Inclusion in this directory is not an endorsement.